Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells

Daniel Chauss,Tilo Freiwald,Reuben McGregor,Bingyu Yan,Luopin Wang,Estefania Nova-Lamperti,Dhaneshwar Kumar,Zonghao Zhang,Heather Teague,Erin E West,Kevin M Vannella,Marcos J Ramos-Benitez,Jack Bibby,Audrey Kelly,Amna Malik,Alexandra F Freeman,Daniella M Schwartz,Didier Portilla,Daniel S Chertow,Susan John,Paul Lavender,Claudia Kemper,Giovanna Lombardi,Nehal N Mehta,Nichola Cooper,Michail S Lionakis,Arian Laurence,Majid Kazemian,Behdad Afzali
DOI: https://doi.org/10.1038/s41590-021-01080-3
Abstract:The molecular mechanisms governing orderly shutdown and retraction of CD4+ type 1 helper T (TH1) cell responses remain poorly understood. Here we show that complement triggers contraction of TH1 responses by inducing intrinsic expression of the vitamin D (VitD) receptor and the VitD-activating enzyme CYP27B1, permitting T cells to both activate and respond to VitD. VitD then initiated the transition from pro-inflammatory interferon-γ+ TH1 cells to suppressive interleukin-10+ cells. This process was primed by dynamic changes in the epigenetic landscape of CD4+ T cells, generating super-enhancers and recruiting several transcription factors, notably c-JUN, STAT3 and BACH2, which together with VitD receptor shaped the transcriptional response to VitD. Accordingly, VitD did not induce interleukin-10 expression in cells with dysfunctional BACH2 or STAT3. Bronchoalveolar lavage fluid CD4+ T cells of patients with COVID-19 were TH1-skewed and showed de-repression of genes downregulated by VitD, from either lack of substrate (VitD deficiency) and/or abnormal regulation of this system.
What problem does this paper attempt to address?